MedPath

Effect of Intake of Glycin Max (L.) Merr. Peel Extract on Body Fat and Body Weight

Phase 2
Completed
Conditions
Obesity
Interventions
Dietary Supplement: Glycin max(L.) Merr. peel extract
Dietary Supplement: Placebo
Registration Number
NCT02108691
Lead Sponsor
Hanyang University
Brief Summary

The investigators performed a 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Glycin max (L.) Merr. peel extract on decrement of body fat. The investigators measured decrement of body fat parameters , including Body Fat Mass, Percent Body Fat, weight and BMI(body mass index), and monitored their blood pressure.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  • Males and females 19-65 years old
  • BMI(body mass index) ≥ 25 kg/m^2 or WC(Waist Circumference) ≥ 90(men), WC ≥ 85(women)
  • Able to give informed consent
Exclusion Criteria
  • Significant variation in weight(more 10%) in the past 3 months
  • Allergic or hypersensitive to any of the ingredients in the test products
  • History of reaction to any of the test products or of gastrointestinal diseases such as Crohn's disease or gastrointestinal surgery
  • History of alcohol or substance abuse
  • Participation in any other clinical trials within past 2 months
  • Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
  • Pregnant or lactating women etc.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Glycin max(L.) Merr. pell extractGlycin max(L.) Merr. peel extract-
PlaceboPlacebo-
Primary Outcome Measures
NameTimeMethod
Changes in Body Fat Mass8 weeks

Body Fat Mass was measured in study visit 1(0 week) and visit 3(8 week).

Secondary Outcome Measures
NameTimeMethod
Changes in Percent Body Fat8 weeks

Percent Body Fat was measured in study visit 1(0 week) and visit 3(8 week).

Changes in Weight8 weeks

Weight was measured in study visit 1(0 week)and visit 3(8 week).

Changes in BMI(Body Mass Index)8 weeks

BMI(body mass index) was measured in study visit 1(0week) and visit 3(8 week).

Changes in LDLc8 weeks

LDLc was measured in study visit 1(0week) and visit 3(8 week).

Changes in Non-HDLc8 weeks

Non-HDLc was measured in study visit 1(0week) and visit 3(8 week).

Changes in LDLc/HDLc8 weeks

LDLc/HDLc was measured in study visit 1(0week) and visit 3(8 week).

Trial Locations

Locations (1)

Hanyang University

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath